Enimmune Corporation (TPEX:6564)
14.90
-0.40 (-2.61%)
Oct 30, 2026, 1:18 PM CST
| Market Cap | 1.07B -27.8% |
| Revenue (ttm) | 53.45M +26.6% |
| Net Income | -120.88M |
| EPS | -1.68 |
| Shares Out | 72.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 30,551 |
| Open | 15.05 |
| Previous Close | 15.30 |
| Day's Range | 14.65 - 15.25 |
| 52-Week Range | 14.65 - 22.55 |
| Beta | 0.24 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |